Abortion Pill Mifepristone Can Continue To Be Mailed And Sold At Pharmacies After Temporary US Supreme Court Order
The order was signed by Justice Samuel Alito. It is a temporary move while the court takes more time to fully review the case.
Why is this pill important?Most abortions in the US today are done using medication. Typically, this involves two drugs:
-mifepristone
-misoprostol
These pills have become especially important after the 2022 Supreme Court decision that overturned Roe v. Wade, which had protected abortion rights nationwide.
What was the restriction before this?A federal appeals court had recently imposed new limits, which could have:
-Required in-person doctor visits
-Restricted mail delivery of the pill
These rules threatened to reduce access significantly across the country.
Why are states involved?Some Republican-led states, like Louisiana, argue that easy access to abortion pills weakens their abortion bans.
Meanwhile, Democratic-led states have passed laws to:
-Protect doctors who prescribe pills via telehealth
-Allow patients in restrictive states to still access care
How long will this last?This decision is temporary. It will stay in place for about a week while:
-Both sides submit more arguments
-The Supreme Court decides its next step
Who challenged the ruling?Manufacturers of mifepristone filed emergency appeals asking the court to intervene and keep access open.
Reaction from activistsStudents for Life, an anti-abortion group, criticized the decision. Its president argued that the ruling favors pharmaceutical companies and expands access to abortion pills too easily.
What happens next?The Supreme Court will:
-Review detailed arguments from both sides
-Decide whether to keep access as it is or allow restrictions
This case could have a major impact on how abortion is accessed across the United States in the future.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment